costs are managed by rationing care and reducing innovation. Those are lose-lose propositions
You could allow a buy in for those who wanted to pay. What good is innovation if it's priced out of most people's insurances? why do we innovate drugs -pay the costs, and then can't afford them?
it's to the point routine but expensive care is already rationed by insurance companies
